1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-2078.PMID:
19923578.
2. Ko Y, Kariyawasam V, Karnib M, et al. Inflammatory bowel disease environmental risk factors: a population-based case-control study of Middle Eastern Migration to Australia. Clin Gastroenterol Hepatol 2015;13:1453-1463.e1.PMID:
25771246.
3. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008;103:2394-2400.PMID:
18684177.
4. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668-673.PMID:
8549943.
5. Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 2013;62:1153-1159.PMID:
22619368.
6. Ortizo R, Lee SY, Nguyen ET, Jamal MM, Bechtold MM, Nguyen DL. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies. Eur J Gastroenterol Hepatol 2017;29:1064-1070.PMID:
28542115.
9. Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP, Pounder RE. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991;36:1147-1150.PMID:
1864207.
10. Looijer-van Langen M, Hotte N, Dieleman LA, Albert E, Mulder C, Madsen KL. Estrogen receptor-beta signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 2011;300:G621-G626.PMID:
10.1152/ajpgi.00274.2010. PMID:
21252046.
11. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11:411-423.PMID:
15817524.
12. Cutolo M, Sulli A, Straub RH. Estrogen metabolism and autoimmunity. Autoimmun Rev 2012;11:A460-A464.PMID:
22155198.
13. Stewart M, Black K. Choosing a combined oral contraceptive pill. Aust Prescr 2015;38:6-11.PMID:
26648603.
14. Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 2011;342:d2139. PMID:
10.1136/bmj.d2139. PMID:
21511804.
15. Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 2011;342:d2151. PMID:
10.1136/bmj.d2151. PMID:
21511805.
16. Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110:587-593.PMID:
17766604.
17. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;339:b2921. PMID:
10.1136/bmj.b2921. PMID:
19679614.
18. Dinger JC, Heinemann LA, Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344-354.PMID:
17434015.
19. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005;90:3863-3870.PMID:
15814774.
20. Han DY, Fraser AG, Dryland P, Ferguson LR. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res 2010;690:116-122.PMID:
19751746.
21. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010;25:325-333.PMID:
20074146.
22. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006;101:993-1002.PMID:
16696783.
23. Vcev A, Pezerovic D, Jovanovic Z, Nakic D, Vcev I, Majnarić L. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010. Wien Klin Wochenschr 2015;127:345-354.PMID:
25821054.
24. Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis 2011;5:577-584.PMID:
22115378.
25. Jiang L, Xia B, Li J, et al. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol 2007;41:280-284.PMID:
17426467.
26. Sicilia B, Arribas F, Nerín J, López Miguel C, Vicente R, Gomollón F. Risk factors for ulcerative colitis: a population-based, case-control study in Spain. J Crohns Colitis 2008;2:158-161.PMID:
21172206.
27. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis 2012;18:1164-1176.PMID:
21887729.
28. Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015;64:1063-1071.PMID:
25217388.
29. Ng SC, Zeng Z, Niewiadomski O, et al. Early course of inflammatory bowel disease in a Population-Based Inception Cohort Study from 8 countries in Asia and Australia. Gastroenterology 2016;150:86-95.e3.PMID:
26385074.
30. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-165.PMID:
23583432.
31. Selinger CP, Andrews JM, Titman A, et al. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2014;12:644-650.PMID:
23707778.
32. Selinger CP, Andrews J, Dent OF, et al. Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2013;19:1880-1888.PMID:
23765177.
33. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006;12:925-933.PMID:
17012962.
34. Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease: a population based study 2007-2009. J Crohns Colitis 2013;7:79-88.PMID:
22748696.
35. Vind I, Riis L, Jespersgaard C, et al. Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005. J Crohns Colitis 2008;2:162-169.PMID:
21172207.
36. García Rodríguez LA, González-Pérez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-315.PMID:
16097997.
37. Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology 1992;3:374-378.PMID:
1637902.
38. Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab 2013;27:3-12.PMID:
23384741.
39. Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 2004;53:246-250.PMID:
14724158.
40. Sicilia B, López Miguel C, Arribas F, López Zaborras J, Sierra E, Gomollón F. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain. Dig Liver Dis 2001;33:762-767.PMID:
11838611.
41. Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO. The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod 1999;14:1493-1499.PMID:
10359554.
42. Wilson NM, Laursen M, Lidegaard Ø. Oral contraception in Denmark 1998-2010. Acta Obstet Gynecol Scand 2012;91:810-815.PMID:
22486520.